[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Europe Drugs for Osteoarthritis Pain Market Report 2017

January 2017 | 121 pages | ID: E1F748675A6EN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Drugs for Osteoarthritis Pain

Revenue, means the sales value of Drugs for Osteoarthritis Pain

This report studies sales (consumption) of Drugs for Osteoarthritis Pain in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
  • Abbott Laboratories
  • Johnson & Johnson
  • Novartis International
  • Pfizer
  • AbbVie
  • Abiogen Pharma
  • Afferent Pharmaceuticals
  • Astellas Pharma
  • BioDelivery Sciences International
  • CrystalGenomics
  • Cytori Therapeutics
  • Daiichi Sankyo
  • Eli Lilly
  • Endo Pharmaceuticals Holdings
  • Horizon Pharma
  • ICeutica
  • Iroko Pharmaceuticals
  • Merck
  • Nuvo Research
  • Regeneron Pharmaceuticals
  • Sanofi
  • SantoSolve
  • Techfields Pharma
  • Winston Pharmaceuticals
  • Yooyoung Pharmaceutical
  • Zynerba Pharmaceuticals
Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Drugs for Osteoarthritis Pain in these countries, from 2011 to 2021 (forecast), like
  • Germany
  • France
  • UK
  • Russia
  • Italy
  • Spain
  • Benelux
Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • OTC
  • Prescription
Split by application, this report focuses on sales, market share and growth rate of Drugs for Osteoarthritis Pain in each application, can be divided into
  • Hospital
  • Clinics
  • Household
Europe Drugs for Osteoarthritis Pain Market Report 2017

1 DRUGS FOR OSTEOARTHRITIS PAIN OVERVIEW

1.1 Product Overview and Scope of Drugs for Osteoarthritis Pain
1.2 Classification of Drugs for Osteoarthritis Pain
  1.2.1 OTC
  1.2.2 Prescription
1.3 Application of Drugs for Osteoarthritis Pain
  1.3.1 Hospital
  1.3.2 Clinics
  1.3.3 Household
1.4 Drugs for Osteoarthritis Pain Market by Countries
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Russia Status and Prospect (2011-2021)
  1.4.5 Italy Status and Prospect (2011-2021)
  1.4.6 Spain Status and Prospect (2011-2021)
  1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Drugs for Osteoarthritis Pain (2011-2021)
  1.5.1 Europe Drugs for Osteoarthritis Pain Sales and Growth Rate (2011-2021)
  1.5.2 Europe Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2021)

2 EUROPE DRUGS FOR OSTEOARTHRITIS PAIN BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Drugs for Osteoarthritis Pain Market Competition by Manufacturers
  2.1.1 Europe Drugs for Osteoarthritis Pain Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Drugs for Osteoarthritis Pain Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Drugs for Osteoarthritis Pain (Volume and Value) by Type
  2.2.1 Europe Drugs for Osteoarthritis Pain Sales and Market Share by Type (2011-2016)
  2.2.2 Europe Drugs for Osteoarthritis Pain Revenue and Market Share by Type (2011-2016)
2.3 Europe Drugs for Osteoarthritis Pain (Volume and Value) by Countries
  2.3.1 Europe Drugs for Osteoarthritis Pain Sales and Market Share by Countries (2011-2016)
  2.3.2 Europe Drugs for Osteoarthritis Pain Revenue and Market Share by Countries (2011-2016)
2.4 Europe Drugs for Osteoarthritis Pain (Volume) by Application

3 GERMANY DRUGS FOR OSTEOARTHRITIS PAIN (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Drugs for Osteoarthritis Pain Sales and Value (2011-2016)
  3.1.1 Germany Drugs for Osteoarthritis Pain Sales and Growth Rate (2011-2016)
  3.1.2 Germany Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2016)
  3.1.3 Germany Drugs for Osteoarthritis Pain Sales Price Trend (2011-2016)
3.2 Germany Drugs for Osteoarthritis Pain Sales and Market Share by Manufacturers
3.3 Germany Drugs for Osteoarthritis Pain Sales and Market Share by Type
3.4 Germany Drugs for Osteoarthritis Pain Sales and Market Share by Application

4 FRANCE DRUGS FOR OSTEOARTHRITIS PAIN (VOLUME, VALUE AND SALES PRICE)

4.1 France Drugs for Osteoarthritis Pain Sales and Value (2011-2016)
  4.1.1 France Drugs for Osteoarthritis Pain Sales and Growth Rate (2011-2016)
  4.1.2 France Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2016)
  4.1.4 France Drugs for Osteoarthritis Pain Sales Price Trend (2011-2016)
4.2 France Drugs for Osteoarthritis Pain Sales and Market Share by Manufacturers
4.3 France Drugs for Osteoarthritis Pain Sales and Market Share by Type
4.4 France Drugs for Osteoarthritis Pain Sales and Market Share by Application

5 UK DRUGS FOR OSTEOARTHRITIS PAIN (VOLUME, VALUE AND SALES PRICE)

5.1 UK Drugs for Osteoarthritis Pain Sales and Value (2011-2016)
  5.1.1 UK Drugs for Osteoarthritis Pain Sales and Growth Rate (2011-2016)
  5.1.2 UK Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2016)
  5.1.5 UK Drugs for Osteoarthritis Pain Sales Price Trend (2011-2016)
5.2 UK Drugs for Osteoarthritis Pain Sales and Market Share by Manufacturers
5.3 UK Drugs for Osteoarthritis Pain Sales and Market Share by Type
5.4 UK Drugs for Osteoarthritis Pain Sales and Market Share by Application

6 RUSSIA DRUGS FOR OSTEOARTHRITIS PAIN (VOLUME, VALUE AND SALES PRICE)

6.1 Russia Drugs for Osteoarthritis Pain Sales and Value (2011-2016)
  6.1.1 Russia Drugs for Osteoarthritis Pain Sales and Growth Rate (2011-2016)
  6.1.2 Russia Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2016)
  6.1.6 Russia Drugs for Osteoarthritis Pain Sales Price Trend (2011-2016)
6.2 Russia Drugs for Osteoarthritis Pain Sales and Market Share by Manufacturers
6.3 Russia Drugs for Osteoarthritis Pain Sales and Market Share by Type
6.4 Russia Drugs for Osteoarthritis Pain Sales and Market Share by Application

7 ITALY DRUGS FOR OSTEOARTHRITIS PAIN (VOLUME, VALUE AND SALES PRICE)

7.1 Italy Drugs for Osteoarthritis Pain Sales and Value (2011-2016)
  7.1.1 Italy Drugs for Osteoarthritis Pain Sales and Growth Rate (2011-2016)
  7.1.2 Italy Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2016)
  7.1.7 Italy Drugs for Osteoarthritis Pain Sales Price Trend (2011-2016)
7.2 Italy Drugs for Osteoarthritis Pain Sales and Market Share by Manufacturers
7.3 Italy Drugs for Osteoarthritis Pain Sales and Market Share by Type
7.4 Italy Drugs for Osteoarthritis Pain Sales and Market Share by Application

8 SPAIN DRUGS FOR OSTEOARTHRITIS PAIN (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Drugs for Osteoarthritis Pain Sales and Value (2011-2016)
  8.1.1 Spain Drugs for Osteoarthritis Pain Sales and Growth Rate (2011-2016)
  8.1.2 Spain Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2016)
  8.1.8 Spain Drugs for Osteoarthritis Pain Sales Price Trend (2011-2016)
8.2 Spain Drugs for Osteoarthritis Pain Sales and Market Share by Manufacturers
8.3 Spain Drugs for Osteoarthritis Pain Sales and Market Share by Type
8.4 Spain Drugs for Osteoarthritis Pain Sales and Market Share by Application

9 BENELUX DRUGS FOR OSTEOARTHRITIS PAIN (VOLUME, VALUE AND SALES PRICE)

9.1 Benelux Drugs for Osteoarthritis Pain Sales and Value (2011-2016)
  9.1.1 Benelux Drugs for Osteoarthritis Pain Sales and Growth Rate (2011-2016)
  9.1.2 Benelux Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2016)
  9.1.9 Benelux Drugs for Osteoarthritis Pain Sales Price Trend (2011-2016)
9.2 Benelux Drugs for Osteoarthritis Pain Sales and Market Share by Manufacturers
9.3 Benelux Drugs for Osteoarthritis Pain Sales and Market Share by Type
9.4 Benelux Drugs for Osteoarthritis Pain Sales and Market Share by Application

10 EUROPE DRUGS FOR OSTEOARTHRITIS PAIN MANUFACTURERS ANALYSIS

10.1 Abbott Laboratories
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification
    10.1.2.1 OTC
    10.1.2.2 Prescription
  10.1.3 Abbott Laboratories Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
  10.1.4 Main Business/Business Overview
10.2 Johnson & Johnson
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification
    10.2.2.1 OTC
    10.2.2.2 Prescription
  10.2.3 Johnson & Johnson Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
  10.2.4 Main Business/Business Overview
10.3 Novartis International
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification
    10.3.2.1 OTC
    10.3.2.2 Prescription
  10.3.3 Novartis International Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
  10.3.4 Main Business/Business Overview
10.4 Pfizer
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification
    10.4.2.1 OTC
    10.4.2.2 Prescription
  10.4.3 Pfizer Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
  10.4.4 Main Business/Business Overview
10.5 AbbVie
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification
    10.5.2.1 OTC
    10.5.2.2 Prescription
  10.5.3 AbbVie Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
  10.5.4 Main Business/Business Overview
10.6 Abiogen Pharma
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification
    10.6.2.1 OTC
    10.6.2.2 Prescription
  10.6.3 Abiogen Pharma Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
  10.6.4 Main Business/Business Overview
10.7 Afferent Pharmaceuticals
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification
    10.7.2.1 OTC
    10.7.2.2 Prescription
  10.7.3 Afferent Pharmaceuticals Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
  10.7.4 Main Business/Business Overview
10.8 Astellas Pharma
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification
    10.8.2.1 OTC
    10.8.2.2 Prescription
  10.8.3 Astellas Pharma Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
  10.8.4 Main Business/Business Overview
10.9 BioDelivery Sciences International
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification
    10.9.2.1 OTC
    10.9.2.2 Prescription
  10.9.3 BioDelivery Sciences International Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
  10.9.4 Main Business/Business Overview
10.10 CrystalGenomics
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Drugs for Osteoarthritis Pain Product Type, Application and Specification
    10.10.2.1 OTC
    10.10.2.2 Prescription
  10.10.3 CrystalGenomics Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
  10.10.4 Main Business/Business Overview
10.11 Cytori Therapeutics
10.12 Daiichi Sankyo
10.13 Eli Lilly
10.14 Endo Pharmaceuticals Holdings
10.15 Horizon Pharma
10.16 ICeutica
10.17 Iroko Pharmaceuticals
10.18 Merck
10.19 Nuvo Research
10.20 Regeneron Pharmaceuticals
10.21 Sanofi
10.22 SantoSolve
10.23 Techfields Pharma
10.24 Winston Pharmaceuticals
10.25 Yooyoung Pharmaceutical
10.26 Zynerba Pharmaceuticals

11 DRUGS FOR OSTEOARTHRITIS PAIN MANUFACTURING COST ANALYSIS

11.1 Drugs for Osteoarthritis Pain Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Drugs for Osteoarthritis Pain

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Drugs for Osteoarthritis Pain Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Drugs for Osteoarthritis Pain Major Manufacturers in 2015
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 EUROPE DRUGS FOR OSTEOARTHRITIS PAIN MARKET FORECAST (2016-2021)

14.1 Germany Drugs for Osteoarthritis Pain Sales Forecast (2016-2021)
14.2 France Drugs for Osteoarthritis Pain Sales Forecast (2016-2021)
14.3 UK Drugs for Osteoarthritis Pain Sales Forecast (2016-2021)
14.4 Russia Drugs for Osteoarthritis Pain Sales Forecast (2016-2021)
14.5 Italy Drugs for Osteoarthritis Pain Sales Forecast (2016-2021)
14.6 Spain Drugs for Osteoarthritis Pain Sales Forecast (2016-2021)
14.7 Benelux Drugs for Osteoarthritis Pain Sales Forecast (2016-2021)
14.8 Europe Drugs for Osteoarthritis Pain Sales Forecast by Type (2016-2021)
14.9 Europe Drugs for Osteoarthritis Pain Sales Forecast by Application (2016-2021)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of Drugs for Osteoarthritis Pain
Table Classification of Drugs for Osteoarthritis Pain
Figure Europe Sales Market Share of Drugs for Osteoarthritis Pain by Type in 2015
Figure OTC Picture
Figure Prescription Picture
Table Application of Drugs for Osteoarthritis Pain
Figure Europe Sales Market Share of Drugs for Osteoarthritis Pain by Application in 2015
Figure Hospital Examples
Figure Clinics Examples
Figure Household Examples
Figure Germany Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2021)
Figure France Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2021)
Figure UK Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2021)
Figure Russia Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2021)
Figure Italy Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2021)
Figure Spain Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2021)
Figure Benelux Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2021)
Figure Europe Drugs for Osteoarthritis Pain Sales and Growth Rate (2011-2021)
Figure Europe Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2021)
Table Europe Drugs for Osteoarthritis Pain Sales of Key Manufacturers (2015 and 2016)
Table Europe Drugs for Osteoarthritis Pain Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Drugs for Osteoarthritis Pain Sales Share by Manufacturers
Figure 2016 Drugs for Osteoarthritis Pain Sales Share by Manufacturers
Table Europe Drugs for Osteoarthritis Pain Revenue by Manufacturers (2015 and 2016)
Table Europe Drugs for Osteoarthritis Pain Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Drugs for Osteoarthritis Pain Revenue Share by Manufacturers
Table 2016 Europe Drugs for Osteoarthritis Pain Revenue Share by Manufacturers
Table Europe Drugs for Osteoarthritis Pain Sales and Market Share by Type (2011-2016)
Table Europe Drugs for Osteoarthritis Pain Sales Share by Type (2011-2016)
Figure Sales Market Share of Drugs for Osteoarthritis Pain by Type (2011-2016)
Figure Europe Drugs for Osteoarthritis Pain Sales Growth Rate by Type (2011-2016)
Table Europe Drugs for Osteoarthritis Pain Revenue and Market Share by Type (2011-2016)
Table Europe Drugs for Osteoarthritis Pain Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Drugs for Osteoarthritis Pain by Type (2011-2016)
Figure Europe Drugs for Osteoarthritis Pain Revenue Growth Rate by Type (2011-2016)
Table Europe Drugs for Osteoarthritis Pain Sales and Market Share by Countries (2011-2016)
Table Europe Drugs for Osteoarthritis Pain Sales Share by Countries (2011-2016)
Figure Sales Market Share of Drugs for Osteoarthritis Pain by Countries (2011-2016)
Table Europe Drugs for Osteoarthritis Pain Revenue and Market Share by Countries (2011-2016)
Table Europe Drugs for Osteoarthritis Pain Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Drugs for Osteoarthritis Pain by Countries (2011-2016)
Table Europe Drugs for Osteoarthritis Pain Sales and Market Share by Application (2011-2016)
Table Europe Drugs for Osteoarthritis Pain Sales Share by Application (2011-2016)
Figure Sales Market Share of Drugs for Osteoarthritis Pain by Application (2011-2016)
Figure Germany Drugs for Osteoarthritis Pain Sales and Growth Rate (2011-2016)
Figure Germany Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2016)
Figure Germany Drugs for Osteoarthritis Pain Sales Price Trend (2011-2016)
Table Germany Drugs for Osteoarthritis Pain Sales by Manufacturers (2015 and 2016)
Table Germany Drugs for Osteoarthritis Pain Market Share by Manufacturers (2015 and 2016)
Table Germany Drugs for Osteoarthritis Pain Sales by Type (2015 and 2016)
Table Germany Drugs for Osteoarthritis Pain Market Share by Type (2015 and 2016)
Table Germany Drugs for Osteoarthritis Pain Sales by Application (2015 and 2016)
Table Germany Drugs for Osteoarthritis Pain Market Share by Application (2015 and 2016)
Figure France Drugs for Osteoarthritis Pain Sales and Growth Rate (2011-2016)
Figure France Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2016)
Figure France Drugs for Osteoarthritis Pain Sales Price Trend (2011-2016)
Table France Drugs for Osteoarthritis Pain Sales by Manufacturers (2015 and 2016)
Table France Drugs for Osteoarthritis Pain Market Share by Manufacturers (2015 and 2016)
Table France Drugs for Osteoarthritis Pain Sales by Type (2015 and 2016)
Table France Drugs for Osteoarthritis Pain Market Share by Type (2015 and 2016)
Table France Drugs for Osteoarthritis Pain Sales by Application (2015 and 2016)
Table France Drugs for Osteoarthritis Pain Market Share by Application (2015 and 2016)
Figure UK Drugs for Osteoarthritis Pain Sales and Growth Rate (2011-2016)
Figure UK Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2016)
Figure UK Drugs for Osteoarthritis Pain Sales Price Trend (2011-2016)
Table UK Drugs for Osteoarthritis Pain Sales by Manufacturers (2015 and 2016)
Table UK Drugs for Osteoarthritis Pain Market Share by Manufacturers (2015 and 2016)
Table UK Drugs for Osteoarthritis Pain Sales by Type (2015 and 2016)
Table UK Drugs for Osteoarthritis Pain Market Share by Type (2015 and 2016)
Table UK Drugs for Osteoarthritis Pain Sales by Application (2015 and 2016)
Table UK Drugs for Osteoarthritis Pain Market Share by Application (2015 and 2016)
Figure Russia Drugs for Osteoarthritis Pain Sales and Growth Rate (2011-2016)
Figure Russia Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2016)
Figure Russia Drugs for Osteoarthritis Pain Sales Price Trend (2011-2016)
Table Russia Drugs for Osteoarthritis Pain Sales by Manufacturers (2015 and 2016)
Table Russia Drugs for Osteoarthritis Pain Market Share by Manufacturers (2015 and 2016)
Table Russia Drugs for Osteoarthritis Pain Sales by Type (2015 and 2016)
Table Russia Drugs for Osteoarthritis Pain Market Share by Type (2015 and 2016)
Table Russia Drugs for Osteoarthritis Pain Sales by Application (2015 and 2016)
Table Russia Drugs for Osteoarthritis Pain Market Share by Application (2015 and 2016)
Figure Italy Drugs for Osteoarthritis Pain Sales and Growth Rate (2011-2016)
Figure Italy Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2016)
Figure Italy Drugs for Osteoarthritis Pain Sales Price Trend (2011-2016)
Table Italy Drugs for Osteoarthritis Pain Sales by Manufacturers (2015 and 2016)
Table Italy Drugs for Osteoarthritis Pain Market Share by Manufacturers (2015 and 2016)
Table Italy Drugs for Osteoarthritis Pain Sales by Type (2015 and 2016)
Table Italy Drugs for Osteoarthritis Pain Market Share by Type (2015 and 2016)
Table Italy Drugs for Osteoarthritis Pain Sales by Application (2015 and 2016)
Table Italy Drugs for Osteoarthritis Pain Market Share by Application (2015 and 2016)
Figure Spain Drugs for Osteoarthritis Pain Sales and Growth Rate (2011-2016)
Figure Spain Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2016)
Figure Spain Drugs for Osteoarthritis Pain Sales Price Trend (2011-2016)
Table Spain Drugs for Osteoarthritis Pain Sales by Manufacturers (2015 and 2016)
Table Spain Drugs for Osteoarthritis Pain Market Share by Manufacturers (2015 and 2016)
Table Spain Drugs for Osteoarthritis Pain Sales by Type (2015 and 2016)
Table Spain Drugs for Osteoarthritis Pain Market Share by Type (2015 and 2016)
Table Spain Drugs for Osteoarthritis Pain Sales by Application (2015 and 2016)
Table Spain Drugs for Osteoarthritis Pain Market Share by Application (2015 and 2016)
Figure Benelux Drugs for Osteoarthritis Pain Sales and Growth Rate (2011-2016)
Figure Benelux Drugs for Osteoarthritis Pain Revenue and Growth Rate (2011-2016)
Figure Benelux Drugs for Osteoarthritis Pain Sales Price Trend (2011-2016)
Table Benelux Drugs for Osteoarthritis Pain Sales by Manufacturers (2015 and 2016)
Table Benelux Drugs for Osteoarthritis Pain Market Share by Manufacturers (2015 and 2016)
Table Benelux Drugs for Osteoarthritis Pain Sales by Type (2015 and 2016)
Table Benelux Drugs for Osteoarthritis Pain Market Share by Type (2015 and 2016)
Table Benelux Drugs for Osteoarthritis Pain Sales by Application (2015 and 2016)
Table Benelux Drugs for Osteoarthritis Pain Market Share by Application (2015 and 2016)
Table Drugs for Osteoarthritis Pain Basic Information List
Table Abbott Laboratories Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Abbott Laboratories Drugs for Osteoarthritis Pain Sales Market Share (2011-2016)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
Table Johnson & Johnson Drugs for Osteoarthritis Pain Sales Market Share (2011-2016)
Table Novartis International Basic Information List
Table Novartis International Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis International Drugs for Osteoarthritis Pain Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Drugs for Osteoarthritis Pain Sales Market Share (2011-2016)
Table AbbVie Basic Information List
Table AbbVie Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
Table AbbVie Drugs for Osteoarthritis Pain Sales Market Share (2011-2016)
Table Abiogen Pharma Basic Information List
Table Abiogen Pharma Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abiogen Pharma Drugs for Osteoarthritis Pain Sales Market Share (2011-2016)
Table Afferent Pharmaceuticals Basic Information List
Table Afferent Pharmaceuticals Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
Table Afferent Pharmaceuticals Drugs for Osteoarthritis Pain Sales Market Share (2011-2016)
Table Astellas Pharma Basic Information List
Table Astellas Pharma Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
Table Astellas Pharma Drugs for Osteoarthritis Pain Sales Market Share (2011-2016)
Table BioDelivery Sciences International Basic Information List
Table BioDelivery Sciences International Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
Table BioDelivery Sciences International Drugs for Osteoarthritis Pain Sales Market Share (2011-2016)
Table CrystalGenomics Basic Information List
Table CrystalGenomics Drugs for Osteoarthritis Pain Sales, Revenue, Price and Gross Margin (2011-2016)
Table CrystalGenomics Drugs for Osteoarthritis Pain Sales Market Share (2011-2016)
Table Cytori Therapeutics Basic Information List
Table Daiichi Sankyo Basic Information List
Table Eli Lilly Basic Information List
Table Endo Pharmaceuticals Holdings Basic Information List
Table Horizon Pharma Basic Information List
Table ICeutica Basic Information List
Table Iroko Pharmaceuticals Basic Information List
Table Merck Basic Information List
Table Nuvo Research Basic Information List
Table Regeneron Pharmaceuticals Basic Information List
Table Sanofi Basic Information List
Table SantoSolve Basic Information List
Table Techfields Pharma Basic Information List
Table Winston Pharmaceuticals Basic Information List
Table Yooyoung Pharmaceutical Basic Information List
Table Zynerba Pharmaceuticals Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Drugs for Osteoarthritis Pain
Figure Manufacturing Process Analysis of Drugs for Osteoarthritis Pain
Figure Drugs for Osteoarthritis Pain Industrial Chain Analysis
Table Raw Materials Sources of Drugs for Osteoarthritis Pain Major Manufacturers in 2015
Table Major Buyers of Drugs for Osteoarthritis Pain
Table Distributors/Traders List
Figure Germany Drugs for Osteoarthritis Pain Sales and Growth Rate Forecast (2016-2021)
Figure Germany Drugs for Osteoarthritis Pain Revenue and Growth Rate Forecast (2016-2021)
Figure France Drugs for Osteoarthritis Pain Sales and Growth Rate Forecast (2016-2021)
Figure France Drugs for Osteoarthritis Pain Revenue and Growth Rate Forecast (2016-2021)
Figure UK Drugs for Osteoarthritis Pain Sales and Growth Rate Forecast (2016-2021)
Figure UK Drugs for Osteoarthritis Pain Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Drugs for Osteoarthritis Pain Sales and Growth Rate Forecast (2016-2021)
Figure Russia Drugs for Osteoarthritis Pain Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Drugs for Osteoarthritis Pain Sales and Growth Rate Forecast (2016-2021)
Figure Italy Drugs for Osteoarthritis Pain Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Drugs for Osteoarthritis Pain Sales and Growth Rate Forecast (2016-2021)
Figure Spain Drugs for Osteoarthritis Pain Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Drugs for Osteoarthritis Pain Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Drugs for Osteoarthritis Pain Revenue and Growth Rate Forecast (2016-2021)
Table Europe Drugs for Osteoarthritis Pain Sales Forecast by Type (2016-2021)
Table Europe Drugs for Osteoarthritis Pain Sales Forecast by Application (2016-2021)

More Publications

Need Help?

Ask a Question

Market Reports

All Categories